Drug factory · FDA FEI 3000291692
Chongqing Daxin Pharmaceutical Co., Ltd.
No. 21 Founder Road, Shuitu Town, BeiBei District, Chongqing, China
Problems found, fixed voluntarily at FDA's last inspection, Jun 28, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2015: 0 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Tobramycin | Makes the active ingredient | Genericus, Inc., Pari Respiratory Equipment, Inc. | 70644-899, 24492-850 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 28, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 11, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 29, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.